Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27469411 | 0.84 | MAPT (0.46) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL30445394 | 0.84 | MAOB (0.47) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL25729137 | 0.84 | MAOB (0.42) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL25242610 | 0.84 | MAOB (0.47) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL6550614 | 0.84 | MAPT (0.44) | RAB9ASMN1; SMN2MAPTL3MBTL1NPC1 | |
| SCHEMBL7918745 | 0.83 | ALOX5 (0.41) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL30065511 | 0.82 | CYP2A6 (0.42) | LMNAHDAC6MAOBRAB9AGAA | |
| SCHEMBL24792264 | 0.82 | CYP2A6 (0.42) | LMNAHDAC6MAOBRAB9AGAA | |
| SCHEMBL25232524 | 0.81 | NR4A2 (0.57) | MAOBRAB9ASMN1; SMN2NR4A1NR4A2 | |
| SCHEMBL30445244 | 0.81 | NR4A2 (0.57) | MAOBRAB9ASMN1; SMN2NR4A1NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0838462-B1 | Benzothiophene compounds, intermediates, compositions, and methods | LILLY CO ELI (US) | 2004-02-11 | — | — | EP | disclosed |
| EP-0827959-B1 | Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods | LILLY CO ELI (US) | 2003-12-03 | — | — | EP | disclosed |
| EP-0729956-B1 | Benzothiophene compounds, intermediates, compositions, and methods | LILLY CO ELI (US) | 2001-10-31 | — | — | EP | disclosed |
| EP-1113013-A1 | Benzothiophene compounds, intermediates, compositions and methods | Eli Lilly & Company (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6197790-B1 | OSTEOPOROSIS | ELI LILLY AND COMPANY | 2001-03-06 | — | — | US | disclosed |
| US-6030986-A | POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ESTROGEN INDUCED UTERINE CANCER; OSTEOPOROSIS; RESTENOSIS; CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5998441-A | ANTICHOLESTEROL AGENT; MIXTURE WITH ESTROGEN | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| US-5985897-A | METHODS OF INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, AND CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS, INCLUDING HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY | 1999-11-16 | — | — | US | disclosed |
| US-5986109-A | UROGENITAL DISORDERS, CARDIOVASCULAR DISORDERS AND ANTICARCINOGENIC AGENTS | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5985898-A | INHIBITING HYPERLIPIDEMIA RESULTED FROM ESTROGEN DEFICIENCY DISEASE, REDUCING SERUM CHOLESTEROL, | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5843965-A | Benzo B! thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0838462-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-04-29 | — | — | EP | disclosed |
| EP-0827959-A2 | Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-03-11 | — | — | EP | disclosed |
| US-5723474-A | TREATING POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ANTIESTROGENS | ELI LILLY AND COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| EP-0729956-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5510357-A | POST-MENOPAUSAL SYNDROME, ENDOMETRIOSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510358-A | OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510498-A | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5492922-A | PREVENTING RESTENOSIS | ELI LILLY AND COMPANY (US) | 1996-02-20 | — | — | US | disclosed |
| US-5488058-A | UROGENITAL DISORDERS OR OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-01-30 | — | — | US | disclosed |